Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Warner Chilcott Announces 2011 Financial Guidance
PR-USA.net
Saturday, February 19, 2011 - 11:51am
tags:
Warner Chilcott
Abbott, Ranbaxy settle patent suit
Economic Times, India
Saturday, February 19, 2011 - 11:50am
tags:
Abbott Laboratories, Ranbaxy, lawsuits
3SBio Inc. Schedules Unaudited Fourth Quarter and Fiscal Year 2010 Results
Yahoo/PR NewsWire
Saturday, February 19, 2011 - 11:48am
tags:
3SBio
Why The New Dendreon Analysis Does Matter — And Why It Doesn’t
Forbes
Saturday, February 19, 2011 - 11:39am
tags:
Provenge, prostate cancer, Dendreon
Exelixis shares rise after report on cancer drug
Yahoo/AP
Saturday, February 19, 2011 - 11:38am
tags:
Exelixis, prostate cancer, cabozantinib
The FDA Has the Final Say (and the One After That)
Motley Fool
Saturday, February 19, 2011 - 11:36am
tags:
FDA
An Inside Look at Biotech Investing, Part 2
Motley Fool
Saturday, February 19, 2011 - 11:36am
tags:
biotech stocks
BioMarin Pharma shares slide after earnings report
Yahoo/AP
Saturday, February 19, 2011 - 11:34am
tags:
Biomarin
BNLfood files anti-trust suit against Martek
bizjournals.com
Saturday, February 19, 2011 - 11:33am
tags:
Martek Biosciences, infant formula
Acorda Posts Profit, Outlook
Yahoo/Zacks
Saturday, February 19, 2011 - 11:32am
tags:
Acorda Therapeutics
Dendreon Adds Ammo to Provenge Defense
Minyanville
Saturday, February 19, 2011 - 11:13am
tags:
Dendreon, Provenge
Good News for Bristol-Myers
Yahoo/Zacks
Saturday, February 19, 2011 - 11:12am
tags:
Bristol-Myers Squibb
Genzyme expects writedown for layoffs, up to $23M
Yahoo/AP
Saturday, February 19, 2011 - 11:11am
tags:
Genzyme
Merck Vioxx Accord Spawns Pay-Day Scrap Among Lawyers
Bloomberg
Saturday, February 19, 2011 - 11:10am
tags:
Merck, Vioxx, lawsuits
Top Biotech Takeout Targets in 2011
Minyanville
Friday, February 18, 2011 - 3:32pm
tags:
M&A, biotech, Biogen Idec, Human Genome, Seattle Genetics, GSK, Dendreon, Actelion, Biomarin, Exelixis, Vertex Pharmaceuticals, Celgene, Alexion, Shire, InterMune, Lexicon Pharmaceuticals, Savient, Merck KGaA
Genzyme advances 2nd Gaucher drug
Bizjournals.com
Friday, February 18, 2011 - 3:22pm
tags:
Gaucher disease, Genzyme
Watson’s Bisaro Tells CNBC Generic Lipitor to Be ‘Huge Product’
Bloomberg
Friday, February 18, 2011 - 3:20pm
tags:
Watson Pharmaceuticals, Paul Bisaro, generics, Lipitor, Pfizer
Impax Laboratories gets FDA approval for generic version of antibiotic Adoxa
Yahoo/AP
Friday, February 18, 2011 - 3:19pm
tags:
Impax, FDA, generics, antibiotics, Adoxa
Obama asks judge for clarity on health care ruling
Bizjournals.com
Friday, February 18, 2011 - 3:18pm
tags:
Obama, healthcare reform
PDL Settles MedImmune Dispute
Yahoo/Zacks.com
Friday, February 18, 2011 - 3:17pm
tags:
PDL Biopharma, MedImmune, AstraZeneca, RSV, Synagis, Abbott Laboratories

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.